snyderman nancy lynn MD

snyderman nancy lynn MD is listed in filings as Director at Alkermes plc. This profile follows SEC Form 4 activity through May 22, 2026, including 14 public disclosures. Recent filings connect the profile to Alkermes plc (ALKS), Lyra Therapeutics, Inc. (LYRA), and Axonics, Inc. (AXNX). The current snapshot covers public activity from Jun 14, 2024 to May 22, 2026. Reported amounts are shown as $54.5K to $58.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.